Summary
This narrative review in The Lancet (2022) synthesises current best practice for bladder cancer diagnosis and treatment as of the early 2020s. The authors, a multidisciplinary team of urologists and radiologists, present evidence-based approaches to patient assessment, staging, and therapeutic decision-making. The paper serves as a clinical reference updating diagnostic and treatment standards for practising clinicians.
UK applicability
As a clinical best-practice review published in a leading international journal, the diagnostic and treatment recommendations are broadly applicable to UK clinical practice and aligned with NICE and EORTC guidelines. The paper provides a contemporary reference for UK oncology and urology services, though specific implementation may vary by institutional protocols.
Key measures
Diagnostic accuracy of imaging and pathology; treatment efficacy endpoints; clinical outcomes in bladder cancer management
Outcomes reported
The paper reviews current diagnostic approaches and evidence-based treatment modalities for bladder cancer management. It synthesises best practice recommendations across clinical assessment, imaging, staging, and therapeutic interventions.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.